LIU; Xijie

Patent Applications and Registrations

Patent applications and USPTO patent grants for LIU; Xijie.The latest application filed is for "ret selective inhibitor, preparation method therefor and use thereof".

Company Profile

7.11.13

LIU; Xijie - Beijing CN
- Beijing CN
LIU; Xijie - Beijing City CN
Liu; Xijie - . CN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Ret Selective Inhibitor, Preparation Method Therefor And Use Thereof App 20220289740 - LIU; Zhihua ; et al.	2022-09-15
Fgfr4 Kinase Inhibitor And Preparation Method Therefor And Use Thereof App 20220185811 - WANG; Jinghan ; et al.	2022-06-16
Macrocycle containing aminopyrazole and pyrimidine and pharmaceutical composition and use thereof Grant 11,098,060 - Dai , et al. August 24, 2	2021-08-24
Macrocycle Containing Aminopyrazole And Pyrimidine And Pharmaceutical Composition And Use Thereof App 20200291042 - DAI; Liguang ; et al.	2020-09-17
1,3,5-triazine derivative and method of using same Grant 10,745,383 - Zhao , et al. A	2020-08-18
1,3,5-triazine derivative and method of using same Grant 10654826 -	2020-05-19
Substituted pyrrolopyrimidine CDK inhibitor, pharmaceutical composition containing same and use thereof Grant 10,570,141 - Wang , et al. Feb	2020-02-25
Substituted Pyrrolopyrimidine Cdk Inhibitor, Pharmaceutical Composition Containing Same And Use Thereof App 20190300533 - Wang; Shulong ; et al.	2019-10-03
Pyridine substituted 2-aminopyridine protein kinase inhibitor crystal Grant 10,385,038 - Gong , et al. A	2019-08-20
1,3,5-triazine Derivative And Method Of Using Same App 20190062308 - ZHAO; Na ; et al.	2019-02-28
Antitumor compound targeting IDH2 mutation and method of use thereof Grant 10,155,722 - Wang , et al. Dec	2018-12-18
Pyridine Substituted 2-aminopyridine Protein Kinase Inhibitor Crystal App 20180244649 - GONG; Feng ; et al.	2018-08-30
Antitumor Compound Targeting Idh2 Mutation And Method Of Use Thereof App 20180222853 - WANG; Shulong ; et al.	2018-08-09
Pyridine-substituted 2-aminopyridine protein kinase inhibitors Grant 9,981,946 - Gong , et al. May 29, 2	2018-05-29
Pyridine-substituted 2-aminopyridine Protein Kinase Inhibitors App 20170226084 - GONG; Feng ; et al.	2017-08-10
Substituted 2-aminopyridine protein kinase inhibitor Grant 9,708,295 - Xiao , et al. July 18, 2	2017-07-18
6-arylamino pyridone carboxamide as MEK inhibitors Grant 9,540,396 - Xiao , et al. January 10, 2	2017-01-10
2,4-diamino-6,7-dihydro-5H-pyrrolo[2,3]pyrimidine derivatives as FAK/Pyk2 inhibitors Grant 9,428,508 - Xiao , et al. August 30, 2	2016-08-30
Substituted 2-aminopyridine Protein Kinase Inhibitor App 20160002205 - Xiao; Dengming ; et al.	2016-01-07
Novel 6-arylamino Pyridone Carboxamide As Mek Inhibitors App 20140080804 - Xiao; Dengming ; et al.	2014-03-20
2,4-DIAMINO-6,7-DIHYDRO-5H-PYRROLO[2,3]PYRIMIDINE DERIVATIVES AS FAK/Pyk2 INHIBITORS App 20130281438 - Xiao; Dengming ; et al.	2013-10-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.